Xilio Therapeutics, Inc. (XLO) Earnings
NASDAQ·Healthcare·Biotechnology
$8.16
+2.13%
Mkt Cap $28.36M
EPS — Estimate vs Actual
Mkt Cap
$28.36M
P/E
—
Fwd P/E
—
P/S
1.05
Rev TTM
—
EPS TTM
-$0.42
NASDAQ·Healthcare·Biotechnology
$8.16
+2.13%
Mkt Cap $28.36M
Mkt Cap
$28.36M
P/E
—
Fwd P/E
—
P/S
1.05
Rev TTM
—
EPS TTM
-$0.42